A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands-Reference-Cited by-同舟云学术

A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands

Published:2019-04 Issue: Volume:489 Page:27-38
ISSN:0020-1693
Container-title:Inorganica Chimica Acta
language:en
Short-container-title:Inorganica Chimica Acta

Author:

Tabares Julie Pauline Gaitan,Santos Rodrigo Luis S.R.,Cassiano Jefferson Luiz,Zaim Marcio H.,Honorato João,Batista Alzir A.,Teixeira Sarah F.,Ferreira Adilson Kleber,Viana Rommel B.,Martínez Sandra Quispe,Stábile Antonio Carlos,de Oliveira Silva Denise

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Materials Chemistry,Inorganic Chemistry,Physical and Theoretical Chemistry

Reference127 articles.

1. M. Gielen, E.R.T. Tiekink, Eds. Metallotherapeutic Drugs & Metal-based Diagnostic Agents - The use of metals in medicine, 2005, John Wiley & Sons Ltd., West Sussex.

2. E. Alessio, Ed. Bioinorganic Medicinal Chemistry, 2011, Wiley-VCH Verlag & Co. KGaA, Weinheim.

3. D. de Oliveira Silva. Ruthenium Compounds Targeting Cancer Therapy. In: M. Atta-ur-Rahman, I. Choudhary, Eds, Frontiers in Anti-Cancer Drug Discovery, 2014, Bentham Science Publishers Ltd., Sharjah, vol. 4, pp. 88–156.